- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00753298
A Randomized, Fully-blinded Parallel Groups Study of Catheter Materials Used for Clean Intermittent Catheterisation
November 10, 2021 updated by: Wellspect HealthCare
A Multi-centre, Double-blind, Randomized, Parallel Groups Study Comparing PVC and Polyolefin-based Elastomer (POBE) as Catheter Materials, Outcomes Will be Measured by Subject Perception.
The study is designed as a randomized, double-blind, parallel-group, multi centre study comparing perception and tolerability of investigational product and comparator.
In the randomized part of the study the subjects will be given either LoFric Primo (POBE) or the comparator LoFric Primo (PVC) for use over 4 weeks.
The hypothesis is that subject perception and satisfaction of POBE is equal to or better than for PVC.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
195
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vienna, Austria, A-1090
- Medical University of Vienna, Department of Urology
-
-
-
-
-
Greifswald, Germany, 17487
- NRZ Greifswald
-
Mönchengladbach, Germany, 41063
- Kliniken Maria Hilf GmbH, Zentrum für Kontinenz und Neuro-Urologie, Krankenhaus St. Franziskus
-
Tübingen, Germany, 72076
- BG-Klinik Tübingen
-
-
-
-
-
Firenze, Italy, 50139
- Ospedale Careggi, Unità Spinale
-
Torino, Italy
- Primario U.O. Neuro-Urologia, Direttore Dipartimento delle Mielolesioni
-
-
-
-
-
Bergen op Zoom, Netherlands, 4624 VT
- Ziekenhuis Lievensberg, Afdeling Urologie
-
Dordrecht, Netherlands, 3300 AK
- Albert Schweitzer Ziekenhuis, locatie Dordwijk
-
Eindhoven, Netherlands, 5602 ZA
- Catharina Ziekenhuis
-
Nijmegen, Netherlands, 6500 HB
- Radboud Univesity Nijmegen Medical Centre
-
-
-
-
-
Göteborg, Sweden, 413 45
- Verksamhet Urologi, Sahlgrenska Universitets sjukhuset
-
-
-
-
-
Sheffield, United Kingdom, S10 2JF
- Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital
-
Stanmore, United Kingdom, HA7 4LP
- Royal National Orthopaedic Hospital, Spinal Injuries Unit, Brockley Hill Stanmore
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Provision of informed consent
- Males and females aged 18 years and over
- Experienced users of LoFric Primo with a minimum of one month of use
- Practice CIC with LoFric Primo at least 3 times per day
- Adults able to read, write and understand information given to them regarding the study
Exclusion Criteria:
- Ongoing symptomatic UTI
- Suspicions of possible poor compliance with CIC during the study period
- Previous enrolment or randomisation of treatment in the present study
- Pregnancy
- Subjects not able to perform self-catheterisation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: LoFric Primo (POBE) single-use urinary catheter
|
LoFric Primo (POBE) single-use urinary catheter
|
ACTIVE_COMPARATOR: LoFric Primo (PVC) single-use urinary catheter
|
LoFric Primo (PVC) single-use urinary catheter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subject's Perception Regarding Handling of Test Catheter Before Insertion
Time Frame: At 4 weeks
|
Subject's perception regarding handling of test catheter before insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
|
At 4 weeks
|
Subject's Perception Regarding Handling of Test Catheter at Insertion
Time Frame: At 4 weeks
|
Subject's perception regarding handling of test catheter at insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
|
At 4 weeks
|
Subject's Perception Regarding Handling of Test Catheter at Withdrawal
Time Frame: At 4 weeks
|
Subject's perception regarding handling of test catheter at withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
|
At 4 weeks
|
Subject's Perception Regarding Handling of Test Catheter After Withdrawal
Time Frame: At 4 weeks
|
Subject's perception regarding handling of test catheter after withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
|
At 4 weeks
|
Subject's General Satisfaction With Test Catheter
Time Frame: At 4 weeks
|
Subject's general satisfaction with test catheter, measured by mean score on a scale from 1 (Very satisfied) to 5 (Absolutely not satified)
|
At 4 weeks
|
Subject's Sensation When Using Test Catheter
Time Frame: At 4 weeks
|
Subject's sensation when using test catheter, measured by mean score on a scale from 1 (Comfortable) to 6 (Severe pain)
|
At 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Alfred J Witjes, Prof Dr, Radboud Univesity Nijmegen Medical Centre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (ACTUAL)
March 1, 2008
Study Completion (ACTUAL)
March 1, 2008
Study Registration Dates
First Submitted
September 15, 2008
First Submitted That Met QC Criteria
September 15, 2008
First Posted (ESTIMATE)
September 16, 2008
Study Record Updates
Last Update Posted (ACTUAL)
November 11, 2021
Last Update Submitted That Met QC Criteria
November 10, 2021
Last Verified
September 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- YA-CLO-0002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Catheterization
-
Wellspect HealthCareCompletedCatheterization (Clean, Intermittent Urinary Catheterization)Sweden
-
Wellspect HealthCareCompletedUrinary CatheterizationSweden
-
Ayşe AKBIYIKCompletedUrine Leakage in the Indwelling Urinary Catheterization
-
Qilu Hospital of Shandong UniversityUnknownCatheterization, Peripheral | Catheterization, Central VenousChina
-
Ain Shams Maternity HospitalWorld Health OrganizationUnknownUrinary CatheterizationEgypt
-
Lahey ClinicSpirus Medical, Inc.TerminatedUrinary Retention | Urinary CatheterizationUnited States
-
Becton, Dickinson and CompanyCompleted
-
3MUniversity of NebraskaCompletedCatheterization
Clinical Trials on LoFric Primo (POBE) single-use urinary catheter
-
Wellspect HealthCareCompletedUrinary CatheterizationSweden
-
Hospital Universitario Dr. Jose E. GonzalezCompletedNeurogenic Bladder Due to Spina Bifida (Disorder)
-
Medway NHS Foundation TrustUnknownUrinary RetentionUnited Kingdom
-
Hospices Civils de LyonCompleted